Hong Kong / Melbourne — Jianai, an AI infrastructure platform for life sciences, today announced the signing of a non-binding Memorandum of Understanding with the HKU Business School AI Evaluation Lab (AIEL) to explore academic and research collaboration in areas related to artificial intelligence (AI) evaluation, responsible AI, AI governance, privacy-preserving AI, and healthcare/life-sciences AI.
The MOU was signed on 12 May 2026 in Hong Kong in connection with the Asia Summit on Global Health. The signing was witnessed by His Excellency Scott Dewar, Australian Ambassador to the People’s Republic of China.
The MOU provides an initial framework for engagement between Jianai and AIEL. Potential areas of collaboration include AI evaluation and benchmarking, responsible and trustworthy AI governance, privacy-preserving and regulation-aware AI systems, and evaluation of AI applications in healthcare, life sciences, and medical research contexts.
" This MOU with AIEL reflects our global interest in developing academic dialogue with leading academic organisations in areas such as responsible AI, AI evaluation, and life sciences AI. We look forward to working with AIEL and appreciate the opportunity to mark this important initial step in Hong Kong."
— Nigel Blair, Founder & CEO, Jianai
" The HKU Business School AI Evaluation Lab is interested in rigorous and independent evaluation of AI systems. This MOU provides an initial framework for exploring possible academic discussion with Jianai in areas of mutual interest."
— Professor Zhenhui (Jack) Jiang, Director, HKU Business School AI Evaluation Lab
The HKU Business School AI Evaluation Lab, led by Professor Zhenhui (Jack) Jiang, conducts rigorous evaluation and research on AI systems applied to business, finance, and healthcare. The Lab is part of HKU Business School at the University of Hong Kong, one of Asia's leading business schools.
